SELLAS Life Sciences Group (SLS) Institutional Ownership → A new way to collect income from stocks (From DTI) (Ad) Free SLS Stock Alerts $1.41 +0.05 (+3.68%) (As of 04/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$4.16MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$39.02K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.1,147,324$1.22M0.0%+10.6%3.579% 2/26/2024Virtu Financial LLC59,914$64K0.0%+216.0%0.187% 2/15/2024Vanguard Group Inc.1,147,324$1.22M0.0%+10.6%3.578% 2/13/2024Northern Trust Corp62,437$66K0.0%+58.6%0.195% 2/13/2024Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 12/18/2023Vanguard Group Inc.1,036,906$1.70M0.0%+9.5%3.234% 9/12/2023Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 8/11/2023BlackRock Inc.283,368$445K0.0%+8.4%1.000% 8/11/2023Northern Trust Corp39,360$62K0.0%+31.1%0.139% 5/16/2023State Street Corp97,129$139K0.0%+35.4%0.343% 5/15/2023Equitable Holdings Inc.130,000$186K0.0%+15.0%0.459% 5/12/2023Dimensional Fund Advisors LP31,304$45K0.0%-46.6%0.110% 5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 2/15/2023Virtu Financial LLC18,379$43K0.0%N/A0.089% 2/15/2023Millennium Management LLC61,179$144K0.0%+146.9%0.298% 2/13/2023Wells Fargo & Company MN16,140$38K0.0%+44.9%0.079% 2/13/2023Geode Capital Management LLC188,066$443K0.0%+30.0%0.915% 2/9/2023Dimensional Fund Advisors LP58,592$138K0.0%N/A0.285% 1/18/2023Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022State Street Corp58,206$118K0.0%+13.6%0.283% 11/15/2022Two Sigma Investments LP53,685$108K0.0%+149.8%0.261% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 11/14/2022Renaissance Technologies LLC22,400$45K0.0%-33.8%0.109% 8/13/2022Renaissance Technologies LLC33,838$75K0.0%N/A0.165% 6/7/2022Bank of America Corp DE21,656$145K0.0%-31.9%0.105% 5/16/2022State Street Corp51,236$342K0.0%+36.7%0.249% 5/16/2022Prelude Capital Management LLC31,125$208K0.0%N/A0.152% 2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021Northern Trust Corp24,605$273K0.0%+35.9%0.163% With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (Ad)Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…Sign up here for a FREE workshop to discover one trader’s $213,000 real-money trade! 8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% 8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% (Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, 19 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Highbridge Capital Management LLC ($2.58M), Vanguard Group Inc. ($1.22M), Armistice Capital LLC ($869K), Empery Asset Management LP ($623K), BlackRock Inc. ($445K), Geode Capital Management LLC ($443K), and Prelude Capital Management LLC ($208K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? Of the 17 institutional investors that purchased SELLAS Life Sciences Group stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($1.81M), Armistice Capital LLC ($820K), Vanguard Group Inc. ($311.03K), Opus Capital Group LLC ($120.17K), Virtu Financial LLC ($59.33K), Dimensional Fund Advisors LP ($58.59K), and State Street Corp ($46.14K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 3,503,326 shares in the last 24 months. This purchase volume represents approximately $5.25M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($619.52K), Dimensional Fund Advisors LP ($27.29K), Renaissance Technologies LLC ($11.44K), and Bank of America Corp DE ($10.14K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 668,388 shares in the last 24 months. This volume of shares sold represents approximately $1.38M in transactions. Related Companies: LifeVantage Major Shareholders BioXcel Therapeutics Major Shareholders YS Biopharma Major Shareholders Journey Medical Major Shareholders Corvus Pharmaceuticals Major Shareholders PMV Pharmaceuticals Major Shareholders Enlivex Therapeutics Major Shareholders Assembly Biosciences Major Shareholders Vaxxinity Major Shareholders Carisma Therapeutics Major Shareholders This page (NASDAQ:SLS) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.